Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Antimicrob Agents Chemother
Главные авторы: Yang, Bumhee, Jhun, Byung Woo, Moon, Seong Mi, Lee, Hyun, Park, Hye Yun, Jeon, Kyeongman, Kim, Dae Hun, Kim, Su-Young, Shin, Sung Jae, Daley, Charles L., Koh, Won-Jung
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2017
Предметы:
Clinical Therapeutics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/
https://ncbi.nlm.nih.gov/pubmed/28348153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы